Scientific Opinion on Dietary Reference Values for molybdenum
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-08-01
|
Series: | EFSA Journal |
Subjects: | |
Online Access: | http://www.efsa.europa.eu/en/efsajournal/doc/3333.pdf |
id |
doaj-90f5e9d732b946cd9507950fb03d3046 |
---|---|
record_format |
Article |
spelling |
doaj-90f5e9d732b946cd9507950fb03d30462021-05-02T14:01:43ZengWileyEFSA Journal1831-47322013-08-0111810.2903/j.efsa.2013.3333Scientific Opinion on Dietary Reference Values for molybdenumEFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the regulation of excretion via the urine. Molybdenum deficiency in otherwise healthy humans has not been observed and there are no biomarkers of molybdenum status. Various metabolic balance studies have been performed to establish molybdenum requirements. However, only one balance study, which was performed with a constant diet and under controlled conditions in adult men, was considered to be of sufficient duration. In this small study, balance was reported to be near zero when molybdenum intakes were 22 µg/day. Biochemical changes or symptoms suggestive of molybdenum deficiency were not observed, and it is possible that humans may be able to achieve molybdenum balance at even lower intakes. Data on molybdenum intakes and health outcomes were unavailable for the setting of DRVs for molybdenum. As the evidence required to derive an Average Requirement and a Population Reference Intake was considered insufficient, an Adequate Intake (AI) is proposed. Observed molybdenum intakes from mixed diets in Europe were taken into consideration in setting this value. An AI of 65 µg/day is proposed for adults; a figure that is based on molybdenum intakes at the lower end of the wide range of observed intakes. It is suggested that the adult AI also applies to pregnant and lactating women. An AI is also proposed for infants from seven months and for children based on extrapolation from the adult AI using isometric scaling and the reference body weights of the respective age groups.http://www.efsa.europa.eu/en/efsajournal/doc/3333.pdfmolybdenumAdequate IntakeDietary Reference Value |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
spellingShingle |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on Dietary Reference Values for molybdenum EFSA Journal molybdenum Adequate Intake Dietary Reference Value |
author_facet |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
author_sort |
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) |
title |
Scientific Opinion on Dietary Reference Values for molybdenum |
title_short |
Scientific Opinion on Dietary Reference Values for molybdenum |
title_full |
Scientific Opinion on Dietary Reference Values for molybdenum |
title_fullStr |
Scientific Opinion on Dietary Reference Values for molybdenum |
title_full_unstemmed |
Scientific Opinion on Dietary Reference Values for molybdenum |
title_sort |
scientific opinion on dietary reference values for molybdenum |
publisher |
Wiley |
series |
EFSA Journal |
issn |
1831-4732 |
publishDate |
2013-08-01 |
description |
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for molybdenum. Molybdenum is efficiently and rapidly absorbed at a wide range of intakes, and the body is able to maintain homeostasis through the regulation of excretion via the urine. Molybdenum deficiency in otherwise healthy humans has not been observed and there are no biomarkers of molybdenum status. Various metabolic balance studies have been performed to establish molybdenum requirements. However, only one balance study, which was performed with a constant diet and under controlled conditions in adult men, was considered to be of sufficient duration. In this small study, balance was reported to be near zero when molybdenum intakes were 22 µg/day. Biochemical changes or symptoms suggestive of molybdenum deficiency were not observed, and it is possible that humans may be able to achieve molybdenum balance at even lower intakes. Data on molybdenum intakes and health outcomes were unavailable for the setting of DRVs for molybdenum. As the evidence required to derive an Average Requirement and a Population Reference Intake was considered insufficient, an Adequate Intake (AI) is proposed. Observed molybdenum intakes from mixed diets in Europe were taken into consideration in setting this value. An AI of 65 µg/day is proposed for adults; a figure that is based on molybdenum intakes at the lower end of the wide range of observed intakes. It is suggested that the adult AI also applies to pregnant and lactating women. An AI is also proposed for infants from seven months and for children based on extrapolation from the adult AI using isometric scaling and the reference body weights of the respective age groups. |
topic |
molybdenum Adequate Intake Dietary Reference Value |
url |
http://www.efsa.europa.eu/en/efsajournal/doc/3333.pdf |
work_keys_str_mv |
AT efsapanelondieteticproductsnutritionandallergiesnda scientificopinionondietaryreferencevaluesformolybdenum |
_version_ |
1721490862262714368 |